Decitabine for Poor Graft Function Post Allo-HSCT

Decitabine 6 mg/m2 daily subcutaneously for consecutive 3 days (day 1 to day 3)

5ug/kg/d when absolute neutrophil count ≤ 1.5 × 109/L

Eltrombopag initial dose: 25 mg orally once a day, may increase to up to 75 mg/day, when platelet count ≤ 30 × 109/L; Avatrombopag initial dose: 20 mg orally once a day, may increase to up to 60 mg/day, when platelet count ≤ 30 × 109/L.

10000 U/day when hemoglobin ≤ 85 g/L